Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of mt2 tablets in China. Welcome to wholesale bulk high quality mt2 tablets for sale here from our factory. Good service and reasonable price are available.
MT2 tablets typically refer to tablets containing the ingredient Melanotan II. Melanotan II is an artificially synthesized peptide hormone that belongs to the class of melanocortin receptor agonists. It was initially developed to stimulate skin pigmentation (tanning) and potentially treat certain skin diseases. It activates melanocortin receptors (mainly MC1R) to promote the activity of melanocytes, thereby increasing the production of melanin in the skin and achieving tanning effects. In addition, it may also affect appetite, sexual desire, and fat metabolism, but these effects have not been fully studied or approved for clinical use.
We set an business example here:
1.Quotation
Clear product information and Quantity.
2.Order and Payment
Company: Bank transfer for All kinds of currencies.
Individual buyers: Bitcion, USDT, Western Union
3.Packages, Shipping and Comments
|
|
|
For individual buyers, sensitive chemicals!
Shipping process:
(1)4-8 days
We have established a company in your local area, which is a buyer.
The two companies have complete documents and business to pass through customs, no risk.
The shipping for business is between this two companies, nothing to do with you.
(2)0-2 days
After customs clearance, pick up the goods from the warehouse or deliver them to you.
No purchase record, no signature, warehouse will deliver goods for you!
4.OEM and ODM cooperation
New peptide R&D, New specifications, Packages and Labels customization.
Any other issues of OEM and special specifications, please contact our sales.
Announcement:
Recently, many non compliant companies, teams and even individuals have pretended to be our company and published false sales information on the Internet, cheating foreign customers with unreasonable prices. Please confirm that the domain name of your website is correct and our registered trademark is correct.
please confirm the Trademark of "BLOOM TECH".
|
Customized Bottle Caps And Corks
|
|
our products form
Melanotan II COA
How did Melanotan 2 Tablets become a cultural totem of "body modification"?
Body modification, as an ancient and controversial behavior, has always existed in the long river of human history. From primitive tribal tattoos and punctures to modern cosmetic and gender reassignment surgeries, the forms of body modification continue to evolve, with rich cultural, social, and psychological significance behind them. In recent years, with the development of technology and the diversification of society, body modification has gradually become a subculture phenomenon, attracting more and more people to participate. Melanotan 2, as a substance with unique biological characteristics, may become a cultural totem in the field of body modification in its tablet form (MT2 tablets).
Promote tanning and skin pigmentation
Melanotan 2 is a synthetic melanocortin receptor agonist, a peptide hormone belonging to the alpha melanocyte stimulating hormone (alpha MSH) mimetics. It can bind to the melanocyte stimulating hormone receptor (MC1R) in the human body, activate G protein, and then activate adenylate cyclase, causing an increase in intracellular cyclic adenosine monophosphate (cAMP) levels. CAMP acts as a second messenger, activating protein kinase A (PKA).
PKA phosphorylates a series of downstream target proteins, promoting the expression of tyrosinase genes and the activity of tyrosinase. Tyrosinase is a key enzyme in the synthesis of melanin, catalyzing the gradual oxidation of tyrosine to dopa (DOPA), which in turn synthesizes melanin. Therefore, Melanotan 2 can promote the production of melanin in the skin, making it darker and meeting people's demand for bronze colored skin without prolonged exposure to sunlight, thereby avoiding the risk of skin sunburn and skin cancer.
The impact on sexual behavior
In addition to promoting tanning, Melanotan 2 has also been found to have a certain regulatory effect on sexual behavior.
The specific mechanism may involve the regulation of neurotransmitters in the central nervous system, such as dopamine and nitric oxide. Some studies suggest that Melanotan 2 can enhance sexual desire and may have potential therapeutic effects for individuals with sexual dysfunction. This potential impact on sexual function also increases the attractiveness of Melanotan 2 in the body modification culture, as sexual attraction is an important component of body aesthetics.
Other potential body modification effects
Studies have shown that Melanotan 2 may also have regulatory effects on the body's energy homeostasis, immune system, inflammation, and cardiovascular system. For example, it can reduce food intake and body weight, and induce thermogenic reactions in mouse models.
Promote peripheral nerve regeneration andhave neuroprotective properties in rats, significantly enhancing sensory function recovery after sciatic nerve compression lesions in rats. Although further research is needed on the specific manifestations and safety of these effects in the human body, they provide more possibilities for the potential application of Melanotan 2 in the field of body modification.
Preclinical Frontier Research and Application of Anti-Inflammatory Effects
Core Molecular Mechanisms of Anti-Inflammatory Pathways
The anti-inflammatory effect of MT2 tablets differs from the single-pathway inhibition mode of traditional nonsteroidal anti-inflammatory drugs. Targeted activation of MT2 receptors establishes a multi-dimensional and multi-target inflammatory regulatory network, which also serves as the core theoretical foundation for its preclinical research. After entering the body, the drug specifically binds to MT2 receptors on the surface of tissue cell membranes and initiates multiple downstream signaling cascades.
On the one hand, it suppresses activation of the core NF-κB inflammatory pathway, blocks transcription and translation of inflammatory factors, and markedly reduces the release of pro-inflammatory factors including tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and IL-6, curbing the inflammatory cascade at the source.
On the other hand, it activates the SIRT1/Nrf2 antioxidant and anti-inflammatory pathway to enhance systemic antioxidant capacity and mitigate inflammatory tissue damage induced by accumulation of oxidative stress products.
Meanwhile, it modulates the cGAS-STING signaling pathway to restrain chronic low-grade inflammation triggered by excessive activation of innate immunity. In addition, melanotan II regulate macrophage polarization phenotypes: they inhibit proliferation and activation of pro-inflammatory M1 macrophages and promote differentiation of anti-inflammatory reparative M2 macrophages, remodeling the local immune microenvironment to achieve precise resolution rather than simple suppression of inflammation. This characteristic endows it with unique advantages in chronic inflammatory injury models.
Preclinical Research on Niche Inflammatory Disorders
Beyond classic inflammatory diseases targeted by conventional anti-inflammatory agents, preclinical studies of melanotan II are mostly carried out on niche and refractory inflammatory injury models, filling research gaps in anti-inflammatory intervention for rare conditions.
In the field of neuroinflammation, preclinical animal experiments using niche models of secondary inflammatory injury following focal cerebral ischemia verify that melanotan II can significantly inhibit abnormal expression of TNF-α mRNA in ischemic regions via activating cerebral MT2 receptors, reduce inflammatory apoptosis of neurons, protect primary neurons against oxygen-glucose deprivation injury, and effectively lower the risk of disability caused by secondary inflammatory damage after cerebral ischemia. It provides a new strategy for anti-inflammatory intervention of sequelae from ischemic encephalopathy.
In research on osteoarticular specific inflammation, for niche models of IL-1β-induced inflammatory cartilage degeneration, melanotan II modulate the TGF-β/BMPs pathway to inhibit secretion of cartilage matrix degrading enzymes, alleviate specific inflammatory injury of articular cartilage and block inflammatory apoptosis of chondrocytes. Unlike traditional anti-inflammatory drugs that merely relieve pain symptoms, melanotan II restrain progression of chronic cartilage inflammation at the molecular level and delay osteoarthritic degeneration, supplying preclinical evidence for precise intervention in early degenerative arthritis.
Furthermore, preclinical investigations on niche models of chronic low-grade skin inflammation and allergic dermatitis demonstrate that melanotan II regulate infiltration of skin immune cells, reduce invasive damage of inflammatory cells to epidermal and dermal tissues, and improve the cutaneous inflammatory microenvironment. Free from skin atrophy side effects associated with hormonal drugs, it exhibits promising potential for topical anti-inflammatory application.
Unique Advantages and Limitations of Anti-Inflammatory Preclinical Research
Compared with conventional anti-inflammatory preparations, MT2 tablets demonstrate two core strengths in preclinical studies.
First, they possess strong targeting specificity, exerting effects exclusively on inflammatory pathways mediated by MT2 receptors without interfering with basal physiological functions of normal immune cells, thereby avoiding adverse reactions such as reduced immunity and gastrointestinal injury commonly induced by broad-spectrum anti-inflammatory drugs.
Second, they integrate anti-inflammatory and antioxidant activities, simultaneously eliminating oxidative stress accompanying inflammation and interrupting the vicious cycle of "inflammation–oxidative stress", matching the intervention demands of persistent chronic inflammation.Nevertheless, obvious limitations remain at the current research stage. All existing anti-inflammatory studies stay at cellular and animal preclinical stages lacking validation in large-scale animal models. Moreover, the optimal dosage, duration of action and tissue-specific regulatory mechanisms have not been fully clarified, and research on pharmacodynamic differences across species is scarce, hindering immediate clinical translation.
MT2 refers to the melatonin receptor subtype 2, one of the core functional receptor subtypes in the melatonin signaling pathway. Its discovery and identification relied on iterative advances in molecular biology-based receptor subtyping technologies.
In the early 1990s, researchers successfully isolated two high-affinity melatonin receptors in mammalian brain tissue and peripheral tissues, designated MT1 and MT2 respectively, which thoroughly overturned the previous simplistic understanding of a single melatonin receptor.
Subsequent studies have confirmed that MT2 receptors are widely distributed in various tissues including nerves, cartilage, skin and vascular endothelium, and independently mediate specific biological effects such as anti-inflammation, antioxidation and tissue remodeling.
Based on the targeted pharmacological properties of this receptor, research teams have developed MT2-targeted tablets (melanotan II Tablets).
The formulation specifically focuses on the MT2 receptor activation pathway and avoids side effects caused by non-specific receptor binding, offering a novel targeted tool for precise intervention in inflammatory injury and tissue repair disorders. Relevant formulation optimization and basic verification studies have gradually entered niche preclinical exploration after 2010.
FAQ
As an "MT2 receptor agonist", may its core component not be melatonin?
+
-
Very likely not. Among the approved drugs, remifentanil and tacrolimus are highly selective MT1/MT2 receptor agonists with molecular structures different from melatonin. In drug research, there are more chemically optimized analogues aimed at higher selectivity or longer half-life.
How to cleverly match the "nighttime physiological pulse" of melatonin with its "enteric coated" or "sustained-release" formulation design?
+
-
Excellent oral dosage forms, such as agomelatine sustained-release tablets, aim to simulate the sustained secretion of melatonin for about 10 hours at night under normal physiological conditions, rather than a steep drug peak. This is achieved by controlling the release rate of drugs in a specific pH environment of the intestine to maintain effective receptor occupancy throughout the night.
Why is the timing of medication more important than the dosage when treating non 24-hour sleep wake disorders (such as completely blind patients)?
+
-
Because the core of this obstacle is that the biological clock cannot be synchronized by external light, resulting in a continuous drift of sleep time every day. The key to treatment lies in taking medication at individualized and accurately calculated "time anchors" every day, utilizing the timing effect of the medication to gradually "drag" the free running biological clock back to a 24-hour cycle.
What are the overlooked long-term risks of taking MT2 agonists to "actively reset rhythms" for long-term night shift workers?
+
-
Long term use of medication outside of natural nighttime hours to forcibly alter rhythms may lead to a "loss of synchronization" between the central and peripheral organs (such as the liver and pancreas), theoretically increasing the long-term risk of metabolic disorders, cardiovascular disease, and even certain cancers. This is not a treatment for insomnia, but an active intervention in physiological rhythms, with limited safety data.
What is a commonly underestimated but influential "life factor" in its drug interactions?
+
-
Exposure to blue light at night (such as mobile phones, computer screens). Blue light strongly inhibits the secretion of endogenous melatonin and may interfere with the "night signal" that MT2 receptor agonists attempt to establish, significantly weakening or even offsetting the efficacy of drugs, which is a direct conflict between behavioral and pharmacological interventions.
Hot Tags: mt2 tablets, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale